Cancer Immunotherapy Market

Cancer Immunotherapy Market Segment Analysis

By application to the cancer immunotherapy market is devised into Lung, Breast, Colorectal, Melanoma, Prostate, Head, and Neck. The lung cancer market held the largest share in 2021 and is expected to hold the same position in the forecasted period also. This is leading due to awareness about cancer in people and the need for therapeutics treatment of lung cancer.

Based on end-user, we can divide the market into 3 segments. Hospitals, cancer treatment research centers, and clinics. In this region, hospitals held the largest share of the market due to the widespread use of cancer immunotherapy treatment in hospitals.

Furthermore, the use of this treatment in hospitals is helping the market to grow faster than the forecasted period. It is expected that the hospital’s region will grow at 14.7% CAGR within the forecasted period. North America is expected to hold the market as they are developing new cancer treatment technologies. Their government also taking the initiative to help cancer treatment research centers to develop new technologies as well as asking the key players to help these technologies by investing in their research. This initiative helps the market to grow faster.

[caption id="attachment_14612" align="aligncenter" width="1920"] Cancer Immunotherapy Market | Exactitude Consultancy[/caption]

Cancer Immunotherapy Market Players

The key players leading in the global cancer immunotherapy market include Amgen, Inc., AstraZeneca, PLC, Bayer AG, Bristol-Myers Squibb Company, Eli Lily and Company, F. Hoffmann-La Roche, Ltd. (Genentech, Inc.), Pfizer, Inc., Johnson &Johnson (Janssen Global Services, LLC), Merck KGAA, and Novartis AG

For corporate expansion, these key leaders are implementing strategic formulations such as new medicine development and commercialization, commercial expansion, and distribution agreements. Moreover, these participants are substantially spending on product development, which is fueling revenue generation.

Recent Developments:

• FEB 2023 – NAMMI’S cancer immunotherapy technology received two awards for its technology. NAMMI is awarded for the technology that targets only the specific part of cancer cells without targeting the whole body’s immune system. This technology would be the first to locate cancer cells in cancerous tumors which is very difficult without this technology.
• DEC 2022 – Immunotherapy is a hope for cancer warriors. Now Immunotherapy can be used for breast, head, neck, and cancerous tumors. This news will become a ray of hope for cancer warriors and hospitals also.

 

 Who Should Buy? Or Key Stakeholders

• Investors

• Technology Companies
• Research Organizations
• Hospitals
• Cancer treatment research centers
• Clinics
• Regulatory Authorities
• Institutional & retail players
• Others

Cancer Immunotherapy Market Regional Analysis

The cancer immunotherapy market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

• North America: includes the US, Canada, Mexico
• Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and the Rest of APAC
• Europe: includes the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
• South America: includes Brazil, Argentina, and the Rest of South America
• Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and the Rest of MEA

North America is going to be the dominant region in this market having all the facilities for research in cancer treatment technologies. They are having excellent technologies to trigger the immune system. The high demand for treatment and higher recovery of patients is growing the cancer immunotherapy market. The government also helps the market to grow by taking the initiative by investing in this technology as well as promoting it. The growth of bioinformatics tools is enhancing the drug development process. Those dynamics are helping North America to hold the market.

During the projected period, the Asia- Pacific region is anticipated to generate the second-highest amount of revenue. This might be ascribed to the rising numbers of cancer patients and the need for this technology in hospitals to cure patients. The expansion of the market is anticipated to be driven by the use of hospitals, clinics, and cancer treatment research centers.

[caption id="attachment_14613" align="aligncenter" width="1920"] Cancer Immunotherapy Market | Exactitude Consultancy[/caption]

Key Market Segments: Cancer Immunotherapy Market

Cancer Immunotherapy Market By Type, 2022-2029, (USD Billion)

• Monoclonal Antibodies
• Cancer Vaccines
• Checkpoint Inhibitors
• Immunomodulatory

Cancer Immunotherapy Market Application, 2022-2029, (USD Billion)

• Hospitals
• Lung
• Breast
• Colorectal
• Melanoma
• Prostate
• Head
• Neck

Cancer Immunotherapy Market By End-User Industry, 2022-2029, (USD Billion)

• Hospitals
• Cancer Treatment Research Centers
• Clinics

Cancer Immunotherapy Market By Region, 2022-2029, (USD Billion)

• North America
• Asia Pacific
• Europe
• South America
• Middle East and Africa

Important Countries in All Regions Are Covered.

Exactitude Consultancy Services Key Objectives:

• Increasing sales and market share
• Developing new technology
• Improving profitability
• Entering new markets
• Enhancing brand reputation

Key Question Answered

• What is the expected growth rate of the cancer immunotherapy market over the next 7 years?
• What are the end-user industries driving demand for the cancer immunotherapy market and what is their outlook?
• What are the opportunities for growth in emerging markets such as Asia-Pacific, the Middle East, and Africa?
• How is the economic environment affecting the cancer immunotherapy market, including factors such as interest rates, inflation, and exchange rates?
• What is the expected impact of government policies and regulations on the cancer immunotherapy market?
• What are the key drivers of growth in the cancer immunotherapy market?
• Who are the market’s major players, and what is their market share?
• What are the cancer immunotherapy market's distribution channels and supply chain dynamics?
• What are the technological advancements and innovations in the cancer immunotherapy market and their impact on product development and growth?
• What are the regulatory considerations and their impact on the market?
• What are the challenges faced by players in the cancer immunotherapy market and how are they addressing these challenges?
• What are the opportunities for growth and expansion in the cancer immunotherapy market?

1. Introduction
   
   
   
   1. Market Definition
   
   
   2. Market Segmentation
   
   
   3. Research Timelines
   
   
   4. Assumptions and Limitations
   
   
   
   


2. Research Methodology
   
   
   
   1. Data Mining
      
      
      
      1. Secondary Research
      
      
      2. Primary Research
      
      
      3. Subject-Matter Experts’ Advice
      
      
      
      
   
   
   2. Quality Checks
      
      
      
      1. Final Review
      
      
      
      
   
   
   3. Data Triangulation
      
      
      
      1. Bottom-Up Approach
      
      
      2. Top-Down Approach
      
      
      3. Research Flow
      
      
      
      
   
   
   4. Data Sources
   
   
   
   


3. Executive Summary


4. Market Overview
   
   
   
   1. Global Cancer Immunotherapy Market Outlook
      
      
      
      1. Market Drivers
      
      
      2. Market Restraints
      
      
      3. Market Opportunities
      
      
      
      
   
   
   2. Impact of Covid-19 on the Cancer Immunotherapy Market
   
   
   3. Porter’s five forces model
      
      
      
      1. Threat from new entrants
      
      
      2. Threat from substitutes
      
      
      3. Bargaining power of suppliers
      
      
      4. Bargaining power of customers
      
      
      5. Degree of competition
      
      
      
      
   
   
   4. Industry value chain Analysis
   
   
   
   


5. Global Cancer Immunotherapy Market by Type, 2022-2029, (USD BILLION),
   
   
   
   1. Monoclonal Antibodies
   
   
   2. Cancer Vaccines
   
   
   3. Checkpoint Inhibitors
   
   
   4. Immunomodulatory
   
   
   
   


6. Global Cancer Immunotherapy Market by Application, 2022-2029, (USD BILLION)
   
   
   
   1. Hospital
   
   
   2. Lung
   
   
   3. Breast
   
   
   4. Head
   
   
   5. Neck
   
   
   6. Colorectal
   
   
   7. Melanoma
   
   
   8. Prostate
   
   
   
   


7. Global Cancer Immunotherapy Market by End-user industry, 2022-2029, (USD BILLION)
   
   
   
   1. Hospital
   
   
   2. Clinics
   
   
   3. Cancer treatment research centers
   
   
   
   


8. Global Cancer Immunotherapy Market by Region, 2022-2029, (USD BILLION)
   
   
   
   1. North America
      
      
      
      1. US
      
      
      2. Canada
      
      
      3. Mexico
      
      
      
      
   
   
   2. South America
      
      
      
      1. BRAZIL’S
      
      
      2. Argentina
      
      
      3. Colombia
      
      
      4. Rest Of South America
      
      
      
      
   
   
   3. Europe
      
      
      
      1. GERMAN
      
      
      2. UK
      
      
      3. France
      
      
      4. ITALY’S
      
      
      5. SPAIN’S
      
      
      6. Russia
      
      
      7. Rest Of Europe
      
      
      
      
   
   
   4. THE ASIA Pacific
      
      
      
      1. India
      
      
      2. China
      
      
      3. Japan
      
      
      4. South KOREAN
      
      
      5. AUSTRALIAN
      
      
      6. South-East THE ASIA
      
      
      7. Rest Of THE ASIA Pacific
      
      
      
      
   
   
   5. Middle East and Africa
      
      
      
      1. UAE
      
      
      2. Saudi Arabia
      
      
      3. South Africa
      
      
      4. Rest Of Middle East and Africa
      
      
      
      
   
   
   
   

9. Company Profiles*

(Business Overview, Company Snapshot, Products Offered, Recent Developments)

1. Amgen, Inc.


2. AstraZeneca


3. PLC


4. Bayer AG


5. Bristol-Myers Squibb Company


6. Eli Lily And Company


7. Hoffmann-La Roche, Ltd. (Genentech, Inc.)


8. Pfizer, Inc.


9. Johnson &Johnson (Janssen Global Services, LLC)

*The Company List Is Indicative

LIST OF TABLES

TABLE 1          GLOBAL CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 2          GLOBAL CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 3          GLOBAL CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 4          GLOBAL CANCER IMMUNOTHERAPY MARKET BY REGION (USD BILLION), 2020-2029

TABLE 5          NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 6          NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 7          NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 8          NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 9          US CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 10        US CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 11        US CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 12        CANADA CANCER IMMUNOTHERAPY MARKET BY TYPE (BILLION), 2020-2029

TABLE 13        CANADA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 14        CANADA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 15        MEXICO CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 16        MEXICO CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 17        MEXICO CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 18        REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 19        REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 20        REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 21        SOUTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 22        SOUTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 23        SOUTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 24        SOUTH AMERICA CANCER IMMUNOTHERAPY MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 25        BRAZIL CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 26        BRAZIL CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 27        BRAZIL CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 28        ARGENTINA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 29        ARGENTINA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 30        ARGENTINA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 31        COLOMBIA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 32        COLOMBIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 33        COLOMBIA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 34        REST OF SOUTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 35        REST OF SOUTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 36        REST OF SOUTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 37        ASIA-PACIFIC CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 38        ASIA-PACIFIC CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 39        ASIA-PACIFIC CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 40        ASIA-PACIFIC CANCER IMMUNOTHERAPY MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 41        INDIA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 42        INDIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 43        INDIA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 44        CHINA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 45        CHINA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 46        CHINA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 47        JAPAN CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 48        JAPAN CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 49        JAPAN CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 50        SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 51        SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 52        SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 53        AUSTRALIA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 54        AUSTRALIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 55        AUSTRALIA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 56        REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 57        REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 58        REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 59        EUROPE CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 60        EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 61        EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 62        EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 63        GERMANY CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 64        GERMANY CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 65        GERMANY CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 66        UK CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 67        UK CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 68        UK CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 69        FRANCE CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 70        FRANCE CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 71        FRANCE CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 72        ITALY CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 73        ITALY CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 74        ITALY CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 75        SPAIN CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 76        SPAIN CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 77        SPAIN CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 78        RUSSIA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 79        RUSSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 80        RUSSIA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 81        REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 82        REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 83        REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 84        MIDDLE EAST AND AFRICA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 85        MIDDLE EAST AND AFRICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 86        MIDDLE EAST AND AFRICA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 87        MIDDLE EAST AND AFRICA CANCER IMMUNOTHERAPY MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 88        UAE CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 89        UAE CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 90        UAE CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 91        SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 92        SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 93        SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 94        SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 95        SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 96        SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

TABLE 97        REST OF MIDDLE EAST AND AFRICA CANCER IMMUNOTHERAPY MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 98        REST OF MIDDLE EAST AND AFRICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION (USD BILLION), 2020-2029

TABLE 99        REST OF MIDDLE EAST AND AFRICA CANCER IMMUNOTHERAPY MARKET BY END USER (USD BILLION), 2020-2029

LIST OF FIGURES

FIGURE 1              MARKET DYNAMICS

FIGURE 2              MARKET SEGMENTATION

FIGURE 3              REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4              DATA TRIANGULATION

FIGURE 5              BOTTOM-UP APPROACH

FIGURE 6              TOP-DOWN APPROACH

FIGURE 7              RESEARCH FLOW

FIGURE 8              GLOBAL CANCER IMMUNOTHERAPY MARKET BY TYPE, USD BILLION, 2022-2029

FIGURE 9              GLOBAL CANCER IMMUNOTHERAPY MARKET BY APPLICATION, USD BILLION, 2022-2029

FIGURE 10           GLOBAL CANCER IMMUNOTHERAPY MARKET BY END USER, USD BILLION, 2022-2029

FIGURE 11           GLOBAL CANCER IMMUNOTHERAPY MARKET BY REGION, USD BILLION, 2022-2029

FIGURE 12           PORTER’S FIVE FORCES MODEL

FIGURE 13           GLOBAL CANCER IMMUNOTHERAPY MARKET BY TYPE, 2020

FIGURE 14           GLOBAL CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2020

FIGURE 15           GLOBAL CANCER IMMUNOTHERAPY MARKET BY END USER 2020

FIGURE 16           CANCER IMMUNOTHERAPY MARKET BY REGION 2020

FIGURE 17           MARKET SHARE ANALYSIS

FIGURE 18           AMAGEN INC: COMPANY SNAPSHOT

FIGURE 19           PLC: COMPANY SNAPSHOT

FIGURE 20           BAYER AG: COMPANY SNAPSHOT

FIGURE 21           ASTRAZENECA: COMPANY SNAPSHOT

FIGURE 22           ELI LILY AND COMPANY: COMPANY SNAPSHOT

FIGURE 23           BRISTOL MAYER SQUIB COMPANY: COMPANY SNAPSHOT

FIGURE 24           F. HOFFMAN LA RUCHE: COMPANY SNAPSHOT

FIGURE 25           P FIZER INC: COMPANY SNAPSHOT